位置:首页 > 蛋白库 > LATA_LATPL
LATA_LATPL
ID   LATA_LATPL              Reviewed;        1361 AA.
AC   L7XDS4;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 1.
DT   03-AUG-2022, entry version 37.
DE   RecName: Full=Alpha-latrotoxin-Lp1a {ECO:0000305};
DE            Short=Alpha-LTX-Lp1a {ECO:0000305};
DE   AltName: Full=Alpha-latrotoxin {ECO:0000303|PubMed:23339183};
DE            Short=Alpha-LTX {ECO:0000303|PubMed:23339183};
DE   Flags: Precursor; Fragment;
OS   Latrodectus pallidus (White widow spider).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida; Araneae;
OC   Araneomorphae; Entelegynae; Araneoidea; Theridiidae; Latrodectus.
OX   NCBI_TaxID=256741;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=23339183; DOI=10.1093/molbev/mst011;
RA   Garb J.E., Hayashi C.Y.;
RT   "Molecular evolution of alpha-latrotoxin, the exceptionally potent
RT   vertebrate neurotoxin in black widow spider venom.";
RL   Mol. Biol. Evol. 30:999-1014(2013).
CC   -!- FUNCTION: Presynaptic neurotoxin that causes massive release of
CC       neurotransmitters from vertebrate (but not invertebrate) nerve
CC       terminals and endocrine cells via a complex mechanism involving
CC       activation of receptor(s) and toxin insertion into the plasma membrane
CC       with subsequent pore formation. Binds to neurexin-1-alpha (NRXN1) in a
CC       calcium dependent manner, adhesion G protein-coupled receptor L1
CC       (ADGRL1, also termed latrophilin-1 and calcium-independent receptor of
CC       latrotoxin (CIRL)), and receptor-type tyrosine-protein phosphatase S
CC       (PTPRS), also termed PTP sigma. NRXN1 and PTPRS are suggested to
CC       provide a platform for binding and subsequent pore formation events. In
CC       contrast, binding to ADGRL1 does not involve oligomerization and
CC       channel formation, but direct downstream stimulation of the synaptic
CC       fusion machinery. {ECO:0000250|UniProtKB:P23631}.
CC   -!- SUBUNIT: Homotetramer in membranes. {ECO:0000250|UniProtKB:P23631}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:P23631}. Target
CC       cell membrane {ECO:0000250|UniProtKB:P23631}. Note=Forms a membrane
CC       channel in the prey. {ECO:0000250|UniProtKB:P23631}.
CC   -!- TISSUE SPECIFICITY: Expressed in venom gland, cephalothorax, and
CC       abdomen tissues from both males and females.
CC       {ECO:0000250|UniProtKB:P0DJE4}.
CC   -!- DOMAIN: The H8 helix is predicted to insert into membranes and form
CC       pores by assembling into tetramers. The helix is contained within a
CC       helical bundle domain that undergoes significant conformational changes
CC       during pore formation to allow exposure of the H8 transmembrane helix
CC       and transition of the toxin from a soluble monomer to a transmembrane
CC       tetramer. {ECO:0000250|UniProtKB:Q9XZC0}.
CC   -!- PTM: Processed by furin-like proteases at both the N- and C-termini.
CC   -!- MISCELLANEOUS: Is the main neurotoxin responsible for the human
CC       envenomation syndrome known as latrodectism that results from bites by
CC       Latrodectus species.
CC   -!- SIMILARITY: Belongs to the cationic peptide 01 (latrotoxin) family. 03
CC       (alpha-latrotoxin) subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KC414038; AGD80172.1; -; Genomic_DNA.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   Gene3D; 1.25.40.20; -; 5.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   Pfam; PF12796; Ank_2; 5.
DR   Pfam; PF13637; Ank_4; 2.
DR   Pfam; PF13857; Ank_5; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 20.
DR   SUPFAM; SSF48403; SSF48403; 3.
DR   PROSITE; PS50297; ANK_REP_REGION; 8.
DR   PROSITE; PS50088; ANK_REPEAT; 11.
PE   3: Inferred from homology;
KW   ANK repeat; Cleavage on pair of basic residues; Disulfide bond; Exocytosis;
KW   Membrane; Neurotoxin; Presynaptic neurotoxin; Repeat; Secreted;
KW   Target cell membrane; Target membrane; Toxin; Transmembrane.
FT   CHAIN           1..1179
FT                   /note="Alpha-latrotoxin-Lp1a"
FT                   /id="PRO_0000455430"
FT   PROPEP          1180..>1361
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000455431"
FT   REPEAT          470..501
FT                   /note="ANK 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          505..534
FT                   /note="ANK 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          539..569
FT                   /note="ANK 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          573..602
FT                   /note="ANK 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          606..636
FT                   /note="ANK 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          640..670
FT                   /note="ANK 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          675..703
FT                   /note="ANK 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          709..738
FT                   /note="ANK 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          742..771
FT                   /note="ANK 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          775..804
FT                   /note="ANK 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          808..838
FT                   /note="ANK 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          842..871
FT                   /note="ANK 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          875..904
FT                   /note="ANK 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          908..937
FT                   /note="ANK 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          951..983
FT                   /note="ANK 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          984..1013
FT                   /note="ANK 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1015..1044
FT                   /note="ANK 17"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1048..1077
FT                   /note="ANK 18"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1081..1111
FT                   /note="ANK 19"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1117..1146
FT                   /note="ANK 20"
FT                   /evidence="ECO:0000255"
FT   REGION          218..237
FT                   /note="Helix H8 is the probable transmembrane region of the
FT                   tetrameric pore inserted in the target cell membrane"
FT                   /evidence="ECO:0000250|UniProtKB:Q9XZC0"
FT   REGION          1176..1179
FT                   /note="Furin-like endopeptidase recognition region"
FT                   /evidence="ECO:0000250|UniProtKB:P23631"
FT   DISULFID        393..1046
FT                   /evidence="ECO:0000250|UniProtKB:P23631"
FT   NON_TER         1361
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1361 AA;  152539 MW;  1C2C0B0A9031A8B6 CRC64;
     EGEDLTLEEK AEICSELELQ QKYVDIASNI IGDLSSLPMV GKIVGTIAAA AMTVTHVASG
     RLDIEQTLLG CSDLPFDQIK EILEKRFNEI DRKLESHSAA LEEITKLVEK SISAVEKTRK
     QMNKRFDEVM KSIQDAKVSP IVSKINNFAR YFDTEKERIR GLKLNDYILK LEEPNGILLH
     FKESRTPKDD SLQAPLFSII QERYAVPKSI DDELAFKVLX ALLYGTQTYV SVMFFLLEQY
     SFLANHYYEK GDLEKYDEYF NSLNNVFLDF KSSLVGTGTS NNEGLLDRVL QVLMIVKNSE
     FLKLGKNGVD EMLNSKINLF NKIKEEIEGK QRMTLSETPE NFAQISFDKD ITTPIGDWRD
     GREVRYAVQY ASETLFSKIG HWSDPVNVRE RACPTLRMPV DQTRRNVLVF RKFDNSKPQL
     VGEITPYLSN FIDIDRDLYN AASNPDSAVG FKEFTKLNYD GANIRATFDQ GRTVFHAAAK
     SGNDKIMFGL TFLAKSTELN QPDKKGYTPI HVAADSGNAG IVNLLIQRGV SINSKTFHFL
     QTPLHLAAQR GFVTTFQRLM ESPEININER DKDGFTPLHY AVRGGERILE AFMNQIDIDI
     NAKSDKGLTP FHLAIIKNDW PVASTLLRSK KVDINAVDEN NMTALHYAAI LGYLEIAKQL
     INLKEINANI VSSPGLLSAL HYAILYKHDD VASFLLRSSN VNVNLKALGG ITPLHLAVIQ
     GRKHILSLMF XIGVNIEQQT DEKYTPLHLA AMSKYPELIQ IFLNQGSNFE AKTNSGATPL
     HLATFKGKSQ AALILLNNEV NWRDTDENGQ MPIHGAAMTG LLDVAQAIIS LDATVLDIED
     KNSDTPLNLA AQNFHIDAVK YFIDQGADIN TRNKKGHAPL LAFSKKGNLD MVKYLFDKNA
     NVYIADNDGM NFFYYAVRNG HLNIVKYAMS EKDKFEWSNI DNNRRDECPK EECAISHFAV
     CDAVQFDKIE IVKYFVGTLG NFGICGPLHQ AARYGHLHIV KYLVEEEFLS VDGSKTDTPL
     CYASENGHLA VVQYLVSNGA KVNHDCDNGM TAIDKAITKN HLQVVQFLAA NGVDFRRKNS
     RGATPFLTAV AENAFDIAEY LIREKRQDIN INEQNVDKDT ALHLAVYYKN LQMIKLLVKY
     GIDVTIRNAY DKTALDIATD AKFSIIVEYL KTKSGKFRRE YKSSYGEPSL LQTNKISSFI
     DGKNIEHDHL QFINADNESS QLFSDTVSNI DVIGTLLLVD VLIRYFSKQG YISKESDSAS
     DGITQAAALS ITEKFEDVLN SLHNESVKEQ VDLAEVHGRV YAALKSGRNS RIHQILCSSL
     KSISTLKPED MEELVSVIMN SQSSVSLPEV TDSANEAYGE A
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024